UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NetEase
NTES
|
+$383M |
| 2 |
DXC Technology
DXC
|
+$191M |
| 3 |
American Express
AXP
|
+$187M |
| 4 |
Johnson & Johnson
JNJ
|
+$185M |
| 5 |
TAL Education Group
TAL
|
+$183M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$228M |
| 2 |
Trane Technologies
TT
|
+$133M |
| 3 |
Booking.com
BKNG
|
+$131M |
| 4 |
MON
Monsanto Co
MON
|
+$113M |
| 5 |
EOG Resources
EOG
|
+$105M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.35% |
| 2 | Financials | 15.6% |
| 3 | Healthcare | 12.81% |
| 4 | Consumer Discretionary | 10.96% |
| 5 | Communication Services | 9.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Simon Property Group
SPG
$76.4B
| $441M | 0.37% |
2,567,168
+134,563
| +6% | +$21.9M |
|
52
NVIDIA
NVDA
$4.6T
| $438M | 0.37% |
90,627,280
+1,806,480
| +2% | +$8.97M |
|
53
Elevance Health
ELV
$81.5B
| $435M | 0.37% |
1,931,170
+200,330
| +12% | +$42.7M |
|
|
AET
54
DELISTED
Aetna Inc
AET
| $434M | 0.37% |
2,404,104
-126,134
| -5% | -$21.7M |
|
55
GE Aerospace
GE
$364B
| $433M | 0.37% |
5,180,811
-2,406
| -0% | -$230K |
|
56
Walmart Inc
WMT
$909B
| $428M | 0.36% |
13,015,365
-2,008,608
| -13% | -$61.5M |
|
57
3M
MMM
$91.8B
| $426M | 0.36% |
2,167,013
-83,942
| -4% | -$16.2M |
|
58
Gilead Sciences
GILD
$165B
| $426M | 0.36% |
5,950,929
-376,866
| -6% | -$28.6M |
|
59
Mondelez International
MDLZ
$82.9B
| $425M | 0.36% |
9,935,418
-333,423
| -3% | -$14M |
|
60
Abbott
ABT
$187B
| $423M | 0.36% |
7,411,240
-751,008
| -9% | -$41.6M |
|
61
Accenture
ACN
$106B
| $422M | 0.36% |
2,759,577
+3,952
| +0.1% | +$573K |
|
|
CELG
62
DELISTED
Celgene Corp
CELG
| $419M | 0.36% |
4,014,773
-2,020,097
| -33% | -$228M |
|
63
Union Pacific
UNP
$174B
| $418M | 0.35% |
3,114,980
+85,977
| +3% | +$10.4M |
|
|
64
EOG Resources
EOG
$77.7B
| $396M | 0.34% |
3,667,568
-1,038,945
| -22% | -$105M |
|
65
Texas Instruments
TXN
$248B
| $389M | 0.33% |
3,720,330
-42,082
| -1% | -$4.1M |
|
66
RTX Corp
RTX
$290B
| $355M | 0.3% |
4,426,728
-156,520
| -3% | -$11.9M |
|
67
Nike
NKE
$64.1B
| $355M | 0.3% |
5,672,102
-94,848
| -2% | -$5.45M |
|
68
Cigna
CI
$78.4B
| $343M | 0.29% |
1,686,651
+168,740
| +11% | +$33.6M |
|
69
Thermo Fisher Scientific
TMO
$214B
| $338M | 0.29% |
1,781,182
+11,625
| +0.7% | +$2.23M |
|
70
Salesforce
CRM
$154B
| $336M | 0.28% |
3,285,013
+441,682
| +16% | +$45M |
|
71
Micron Technology
MU
$835B
| $336M | 0.28% |
8,164,261
-73,223
| -0.9% | -$3.15M |
|
72
Bristol-Myers Squibb
BMY
$129B
| $324M | 0.27% |
5,281,003
+387,094
| +8% | +$24.2M |
|
73
Medtronic
MDT
$112B
| $321M | 0.27% |
3,970,709
+690
| +0% | +$55.3K |
|
74
Ecolab
ECL
$79.8B
| $320M | 0.27% |
2,388,218
-30,263
| -1% | -$4.03M |
|
75
Caterpillar
CAT
$361B
| $312M | 0.26% |
1,977,402
+43,775
| +2% | +$6.07M |
|
Similar funds
UBS AM's Q4 2017 Portfolio in Review
As of Q4 2017, UBS AM held 2,665 positions worth $118B, up 7.5% from $110B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS AM's Q4 2017 filing shows 135 new, 1,412 increased, 606 reduced and 93 closed positions. Its largest new stake was Sogou Inc. American Depositary Shares, each representing one Class A Ordinary Share: 2,522,917 shares worth $29.2M. The largest sale was Celgene Corp, an estimated $228M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.
- UBS AM's largest Q4 2017 buy was Sogou Inc. American Depositary Shares, each representing one Class A Ordinary Share: 2,522,917 shares worth $29.2M.
- UBS AM added most to NetEase in Q4 2017, an estimated $383M increase.
- UBS AM's biggest Q4 2017 reduction was Celgene Corp, cutting an estimated $228M.
- UBS AM fully exited CR Bard Inc. in Q4 2017, selling an estimated $67.9M.
- UBS AM's ten largest holdings make up 16% of its $118B portfolio in Q4 2017.
- UBS AM opened 135 new positions and closed 93 in Q4 2017.
- UBS AM's portfolio value rose 7.5% quarter-over-quarter to $118B.
Based on UBS AM's 13F filing for Q4 2017, filed 9 Feb 2018.